USDCAD has displayed bullish momentum, breaking above the key resistance level of 1.3543 and extending its uptrend from 1.3358. This breakout raises questions about the pair’s future direction. Let’s analyze the technicals to understand what this means...
USDJPY has been on a tear, extending its rally from 145.89 to reach a new high of 150.88. But will this bullish momentum continue, or is a correction on the horizon? Let’s delve into the technical analysis...
The AUDUSD pair has made a decisive move, breaking below the key support level of 0.6468 after trading sideways between 0.6468 and 0.6543. This breakdown raises questions about the pair’s future direction. Let’s dive into the technical...
GBPUSD has reached a make-or-break point, testing the key support level at 1.2571. The technical analysis reveals two potential scenarios depending on whether this support holds or not. Scenario 1: Support Holds, Uptrend Resumes Scenario 2: Support...
The EURUSD pair has taken a tumble, breaking below the key support level of 1.0723 and extending its decline from 1.1139 to reach a new low of 1.0700. Let’s break down the technical analysis to understand where...
Visa Inc (NYSE: V) is an American multinational payment card services corporation headquartered in San Francisco, California. It facilitates electronic funds transfers throughout the world, most commonly through Visa-branded credit cards, debit cards and prepaid cards. This article dives...
In this technical blog, we will look at the past performance of the 4-hour Elliott Wave Charts of CHFJPY. In which, the rally from 14 December 2023 low unfolded as an impulse sequence and called for an extension higher...
XPO INC., (XPO) provides freight transportation services in United States, rest of North America, Europe, UK & internationally. It operates in two segments, North American LTL & European Transportation & offers services to different industries. It is...
Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average, and the company is...
Gilead Sciences, Inc. is an US American biopharmaceutical company. It focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir and sofosbuvir. In the 2000s, Gilead received approval for drugs including Viread and Hepsera, among others. It began evolving from...
